SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-002402
Filing Date
2023-11-13
Accepted
2023-11-13 16:02:01
Documents
57
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atxs-20230930x10q.htm   iXBRL 10-Q 1867605
2 EX-31.1 atxs-20230930xex31d1.htm EX-31.1 11348
3 EX-31.2 atxs-20230930xex31d2.htm EX-31.2 11326
4 EX-32.1 atxs-20230930xex32d1.htm EX-32.1 6201
  Complete submission text file 0001410578-23-002402.txt   6268449

Data Files

Seq Description Document Type Size
5 EX-101.SCH atxs-20230930.xsd EX-101.SCH 37334
6 EX-101.CAL atxs-20230930_cal.xml EX-101.CAL 38766
7 EX-101.DEF atxs-20230930_def.xml EX-101.DEF 167290
8 EX-101.LAB atxs-20230930_lab.xml EX-101.LAB 375609
9 EX-101.PRE atxs-20230930_pre.xml EX-101.PRE 257181
51 EXTRACTED XBRL INSTANCE DOCUMENT atxs-20230930x10q_htm.xml XML 966803
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 231398461
SIC: 2834 Pharmaceutical Preparations